Modified expression of molecules belonging to the BTN/BTNL family was reported in clinical studies when an immune checkpoint blockade was applied with PD-1 antibodies, suggesting a role in tumor immune escape [47,48,49]. Here, BTN1A1 is linked to neoplasm.